WAT 📈 Waters - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9418481035
WAT: Chromatography Systems, Mass Spectrometry Instruments, Thermal Analysis Instruments
Waters Corporation is a leading provider of analytical workflow solutions, operating across Asia, the Americas, and Europe through its two primary segments: Waters and TA. The company's product portfolio encompasses a range of high and ultra-performance liquid chromatography systems, as well as mass spectrometry technology systems and support products. This includes chromatography columns and other consumable products, which are essential for various laboratory applications. Additionally, the company offers post-warranty service plans, ensuring that its customers receive comprehensive support for their instruments.
The company's product line also features thermal analysis, rheometry, and calorimetry instruments, which are designed to predict the suitability and stability of various materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments are crucial for industries such as consumer goods, healthcare, and life science research. Furthermore, Waters Corporation develops and supplies software-based products that can interface with its own instruments, as well as those of other manufacturers. This enables customers to streamline their workflows and enhance their analytical capabilities.
Waters Corporation's mass spectrometry technology instruments play a vital role in drug discovery and development, including clinical trial testing and the analysis of proteins in disease processes. The company's products are also used for nutritional safety analysis and environmental testing, highlighting their versatility and importance in various fields. The company's customer base is diverse, comprising clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental organizations. These customers rely on Waters Corporation's products for research and development, quality assurance, and other laboratory applications.
With a history dating back to 1958, Waters Corporation has established itself as a prominent player in the life sciences tools and services industry. Headquartered in Milford, Massachusetts, the company continues to innovate and expand its product offerings, addressing the evolving needs of its customers. Its commitment to delivering high-quality analytical workflow solutions has earned it a reputation as a trusted partner in the scientific community. As a publicly traded company, Waters Corporation's common stock is listed on the New York Stock Exchange, providing investors with an opportunity to participate in its growth and success.
Additional Sources for WAT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
WAT Stock Overview
Market Cap in USD | 22,460m |
Sector | Healthcare |
Industry | Diagnostics & Research |
GiC Sub-Industry | Life Sciences Tools & Services |
IPO / Inception | 1995-11-16 |
WAT Stock Ratings
Growth 5y | 41.2% |
Fundamental | 67.6% |
Dividend | 0.30% |
Rel. Strength Industry | 313 |
Analysts | 3.2/5 |
Fair Price Momentum | 349.66 USD |
Fair Price DCF | 270.21 USD |
WAT Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 1.0% |
WAT Growth Ratios
Growth Correlation 3m | 59.6% |
Growth Correlation 12m | 49% |
Growth Correlation 5y | 48.7% |
CAGR 5y | 9.56% |
CAGR/Mean DD 5y | 0.49 |
Sharpe Ratio 12m | 0.36 |
Alpha | -11.20 |
Beta | 0.85 |
Volatility | 30.38% |
Current Volume | 1737.3k |
Average Volume 20d | 568.1k |
As of December 21, 2024, the stock is trading at USD 368.16 with a total of 1,737,300 shares traded.
Over the past week, the price has changed by -5.85%, over one month by +4.62%, over three months by +6.55% and over the past year by +9.62%.
Yes, based on ValueRay Fundamental Analyses, Waters (NYSE:WAT) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 67.57 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WAT as of December 2024 is 349.66. This means that WAT is currently overvalued and has a potential downside of -5.02%.
Waters has received a consensus analysts rating of 3.20. Therefor, it is recommend to hold WAT.
- Strong Buy: 3
- Buy: 0
- Hold: 15
- Sell: 2
- Strong Sell: 0
According to ValueRays Forecast Model, WAT Waters will be worth about 385.3 in December 2025. The stock is currently trading at 368.16. This means that the stock has a potential upside of +4.66%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 377.8 | 2.6% |
Analysts Target Price | 287.6 | -21.9% |
ValueRay Target Price | 385.3 | 4.7% |